login

Expression of connective tissue growth factor (CCN2) in desmoplastic small round cell tumour

Journal of Clinical PathologyPublished 26 March 2004Open access
Amy W. Rachfal, Mark Luquette, David R. Brigstock
Citations27
SJR quartileQ1
SJR score0.80
SNIP0.88
View PDF

TL;DR

Data show that CCN2 is produced in high amounts by several cell types in DSRCT, and highlight a potential role for this factor in the autocrine and paracrine regulation of tumour cell growth, matrigenesis, and angiogenesis.

Abstract

BACKGROUND: Desmoplastic small round cell tumour (DSRCT) is a rare and often fatal abdominal tumour that is distinguished by well defined islands of cells, surrounded by prominent desmoplastic stroma. As in certain other tumours, the function of the Wilms's tumour protein (WT1) in repressing gene transcription is lost in DSRCT. AIMS: To assess the expression and localisation of connective tissue growth factor (CCN2) in DSRCT because this protein is transcriptionally repressed by WT1 and is associated with the production of abundant extracellular matrix. METHODS: CCN2 was assessed by in situ hybridisation and immunohistochemistry. RESULTS: CCN2 mRNA and protein were colocalised to the tumour cells themselves, in addition to stromal fibroblasts and vascular endothelial cells. CONCLUSIONS: These data show that CCN2 is produced in high amounts by several cell types in DSRCT, and highlight a potential role for this factor in the autocrine and paracrine regulation of tumour cell growth, matrigenesis, and angiogenesis.

Keywords

MedicineBiochemistry, Genetics and Molecular Biology